PERCEPTIVE ADVISORS LLC

Holdings History for Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share (NAUT)

Symbol: NAUT on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common stock, par value $0.0001 per share
Latest Disclosed Ownership: 12.6M shares
Security Ownership: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

Perceptive Advisors LLC ownership in Nautilus Biotechnology, Inc. Common stock, par value $0.0001 per share (NAUT)

2025-01-31 - Perceptive Advisors LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12.6M shares of Nautilus Biotechnology, Inc. Common stock, par value $0.0001 per share (NAUT). This represents 10% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Perceptive Advisors LLC	10%		$21M	12.6M			$1.67	13D/A	1/31/2025	31 Jan 2025 21:06:27

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.59%		$21.2M	12.6M			$1.68	Q4 2024
9/30/2024	0.77%		$35.9M	12.6M			$2.85	Q3 2024
6/30/2024	0.71%		$29.5M	12.6M			$2.34	Q2 2024
3/31/2024	0.65%		$37M	12.6M			$2.94	Q1 2024
12/31/2023	0.84%	+0.35%	$37.7M	12.6M	+3,483,060	+38.2%	$2.99	Q4 2023
9/30/2023	0.96%		$28.8M	9.11M			$3.16	Q3 2023
6/30/2023	1.02%		$35.3M	9.11M			$3.87	Q2 2023
3/31/2023	0.75%		$25.2M	9.11M			$2.77	Q1 2023
12/31/2022	0.46%		$16.4M	9.11M			$1.80	Q4 2022
9/30/2022	0.56%		$19.3M	9.11M			$2.12	Q3 2022
6/30/2022	0.77%		$24.5M	9.11M			$2.69	Q2 2022
3/31/2022	0.79%		$39.5M	9.11M			$4.34	Q1 2022
12/31/2021	0.73%	+0.02%	$47.2M	9.11M	+200,000	+2.24%	$5.18	Q4 2021
9/30/2021	0.8%		$54.7M	8.91M			$6.14	Q3 2021
6/30/2021	1.17%	+1.2%	$90M	8.91M	+8,911,151	NEW	$10.10	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.